文献速递区域麻醉与超声疼痛医学

持续静脉输注利多卡因与腹横肌平面阻滞用于肾移植手术的比较:随机非劣效性试验

Comparison of continuous intravenous lidocaine versus transversus abdominis plane block for kidney transplant surgery: a randomized, non-inferiority trial.
PubMed 文献 · Reg Anesth Pain Med · 2021-08-20

TAP组(14.6±3.2 mg)与Lido组(15.9±2.4 mg)的累积几何均值静脉吗啡当量差异为1.27 mg(95% CI -4.25至6.79;p<0.001),证明持续利多卡因输注非劣效于TAP阻滞,次要结局无临床意义差异。

要点

  • 持续静脉利多卡因在肾移植术后24小时镇痛方面非劣效于TAP阻滞。
  • 两组阿片消耗量差异为1.27 mg(95% CI -4.25至6.79;p<0.001)。
  • 次要结局包括疼痛评分、满意度及阿片相关不良事件无临床意义差异。

核心结论

  • 持续静脉输注利多卡因在肾移植术后24小时内提供与超声引导下单侧单次TAP阻滞非劣效的术后镇痛。

研究设计与样本

  • 随机、非劣效性试验,受试者为接受肾移植手术者,按1:1随机分配至TAP组或Lido组。

主要发现

  • 主要结局术后24小时内阿片消耗量:TAP组累积几何均值静脉吗啡当量为14.6±3.2 mg,Lido组为15.9±2.4 mg。
  • 两组累积几何均值静脉吗啡当量差异为1.27 mg(95% CI -4.25至6.79;p<0.001),证明持续利多卡因输注非劣效。
  • 次要结局包括疼痛评分、患者满意度、阿片相关不良事件、恢复常规饮食时间及持续阿片使用,组间均无临床意义差异。

临床怎么用

  • 对于肾移植手术,持续静脉输注利多卡因可作为TAP阻滞的替代镇痛方案,避免阻滞相关操作风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Transversus abdominis plane (TAP) blocks are associated with an improvement in postoperative analgesia following kidney transplant surgery. However, these blocks carry inherent risk and require a degree of expertise to perform successfully. Continuous intravenous lidocaine may be an effective alternative. In this randomized, non-inferiority study, we hypothesized that a continuous lidocaine infusion provides similar postoperative analgesia to a TAP block. METHODS: Subjects presenting for kidney transplant surgery were randomized in a 1:1 ratio to either an ultrasound-guided unilateral, single-injection TAP block (TAP group) or a continuous infusion of lidocaine (Lido group). The primary outcome of this non-inferiority study was opioid consumption within the first 24 hours following surgery. Secondary outcomes included pain scores, patient satisfaction, opioid-related adverse events, time to regular diet, and persistent opioid use. RESULTS: One hundred and twenty subjects, 59 from the TAP group and 61 from the Lido group, completed the study per protocol. Analysis of the primary outcome showed a cumulative geometric mean intravenous morphine equivalent difference between the TAP (14.6±3.2 mg) and Lido (15.9±2.4 mg) groups of 1.27 mg (95% CI -4.25 to 6.79; p<0.001), demonstrating non-inferiority of the continuous lidocaine infusion. No secondary outcomes showed clinically meaningful differences between groups. CONCLUSIONS: This study demonstrates that a continuous infusion of lidocaine offers non-inferior postoperative analgesia compared with an ultrasound-guided unilateral, single-injection TAP block in the first 24 hours following kidney transplant surgery. TRIAL REGISTRATION NUMBER: NCT03843879.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hanson NA, Strunk J, Saunders G, et al. Comparison of continuous intravenous lidocaine versus transversus abdominis plane block for kidney transplant surgery: a randomized, non-inferiority trial. Reg Anesth Pain Med. 2021. PMID: 34417343. doi:10.1136/rapm-2021-102973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。